Kai Dallmeier Selected Research

Kai Dallmeier Research Topics

Disease

24	Infections 07/2023 - 12/2008
11	COVID-19 01/2023 - 10/2020
9	Yellow Fever 01/2022 - 01/2018
5	Virus Diseases (Viral Diseases) 04/2024 - 12/2011
4	Dengue (Dengue Fever) 04/2024 - 01/2021
2	Japanese Encephalitis 04/2024 - 01/2024
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2016 - 10/2013
1	Arbovirus Infections 08/2023
1	Vesicular Stomatitis 07/2023
1	Breakthrough Infections 01/2022
1	Disease Progression 01/2022
1	Necrosis 08/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Rabies (Hydrophobia) 03/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Bites and Stings (Sting) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hepatitis B 01/2017
1	Persistent Infection 12/2011
1	Chronic Hepatitis C 12/2011
1	Hepatocellular Carcinoma (Hepatoma) 06/2011

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 04/2024 - 01/2018
9	Antiviral Agents (Antivirals)IBA 01/2024 - 12/2011
3	InterferonsIBA 07/2023 - 11/2020
3	AntibodiesIBA 07/2023 - 06/2021
3	Neutralizing AntibodiesIBA 01/2022 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2016
3	Ribavirin (Virazole)FDA LinkGeneric 01/2016 - 12/2011
2	favipiravirIBA 10/2021 - 10/2014
2	Interferon-alpha (Interferon Alfa)IBA 10/2013 - 12/2011
1	Immune Sera (Antisera)IBA 01/2024
1	JNJ-1802IBA 01/2023
1	COVID-19 VaccinesIBA 09/2022
1	Nelfinavir (Viracept)FDA Link 01/2022
1	BNT162 VaccineIBA 01/2022
1	Immunoglobulin G (IgG)IBA 12/2021
1	Broadly Neutralizing AntibodiesIBA 11/2021
1	molnupiravirIBA 10/2021
1	(+)- 4- (3- ((1- (4- chlorophenyl)- 2- oxo2- (6- (trifluoromethoxy)indolin- 1- yl)ethyl)amino)- 5- methoxyphenoxy)butanoic acidIBA 10/2021
1	Granzymes (Granzyme)IBA 08/2021
1	AntigensIBA 01/2021
1	Subgenomic RNAIBA 01/2021
1	ExoribonucleasesIBA 01/2021
1	Viral RNAIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2020
1	InflammasomesIBA 10/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	Japanese Encephalitis VaccinesIBA 01/2020
1	Dengue VaccinesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	BX795IBA 01/2020
1	Attenuated VaccinesIBA 10/2018
1	Peptides (Polypeptides)IBA 01/2017
1	sodium-bile acid cotransporterIBA 01/2017
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 12/2012
1	Polysaccharides (Glycans)IBA 12/2012
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2012
1	Ivermectin (Mectizan)FDA Link 08/2012
1	teicoplanin aglyconeIBA 06/2011
1	Peptide Hydrolases (Proteases)FDA Link 06/2011
1	Viral Envelope ProteinsIBA 12/2008

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2020
1	Off-Label Use 01/2020